GlassScriptPhysician profile
Keyoka Sheree Smith
NPI 1952612871
$868.99
in general payments reported to CMS, 2019-2025
11 companies · $247 in 2025
The $247 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $370 · 2024: $252 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $868.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $302.77 | 2023-2024 | |
| Organogenesis INC. | $289.59 | 2023-2025 | Affinity, Novachor, Via Matrix |
| Horizon Therapeutics Plc | $70.30 | 2023 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $66.70 | 2024-2025 | Nuzyra |
| Smith+Nephew, INC. | $36.26 | 2024 | Grafix Pl, Stravix |
| Cashflow Solutions, LLC | $25.29 | 2023 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Abbvie INC. | $23.17 | 2023 | Dalvance |
| Averitas Pharma INC. | $20.34 | 2023 | Qutenza |
| Bioventus LLC | $13.44 | 2024 | Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $13.36 | 2023 | Intellis Adaptivestim |
| Kerecis Limited | $7.77 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keyoka Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.